Skip to main content
. 2020 Dec 17;59(1):e02287-20. doi: 10.1128/JCM.02287-20

TABLE 4.

Human adenovirus serotypes and acute gastroenteritis illness severitya

Parameter HAdV F40/41 (n = 279)
HAdV non-F40/41 (n = 188)
% difference (95% CI) P value
No. of cases in analysis Value No. of cases in analysis Value
Median age (mo) (IQR) 279 17.1 (10.8, 30.7) 188 15.3 (10.5, 25.4) 1.5 (0.4, 3.5) 0.11
No. of males (%) 279 170 (60.9) 188 109 (58.0) 3.0 (−6.3, 12.3) 0.56
No. of children with vomiting (%) 273 249 (91.2) 182 152 (83.5) 7.7 (1.2, 14.7) 0.02
Median no. of vomiting episodes (IQR)b 257 4 (3, 7) 174 4 (2, 7) 0 (−1, 1) 0.97
Median vomiting duration (h) (IQR) 257 105.1 (54.3, 158.9) 174 60.4 (11.8, 111.5) 38.3 (24.6, 52.3) <0.001
No. of cases with diarrhea (%) 274 262 (95.6) 184 155 (84.2) 11.4 (5.5, 18.0) <0.001
Median no. of diarrhea episodes (IQR)b 257 6 (4, 9) 173 4 (2, 6) 2 (1, 3) <0.001
Median diarrhea duration (h) (IQR) 257 151.1 (94.4, 198.0) 174 115.4 (48.0, 192.0) 31.7 (12.0, 50.4) 0.001
No. of cases with isolated vomiting (%) 273 12 (4.4) 182 29 (15.9) −11.5 (−18.2, −5.7) <0.001
No. of cases with isolated diarrhea (%) 274 24 (8.8) 184 30 (16.3) −7.6 (−14.5, −1.1) 0.02
No. of cases with both vomiting and diarrhea (%) 269 233 (86.6) 178 119 (66.9) 19.8 (11.5, 28.1) <0.001
No. of cases with fever (%)c 267 88 (33.0) 180 131 (72.8) −39.8 (−48.2, −30.4) <0.001
No. of cases with respiratory symptoms (%) 235 121 (51.5) 155 98 (63.2) −11.7 (−21.7, −1.3) 0.03
No. of cases with ED visit after enrollment (%) 257 31 (12.1) 174 21 (12.1) 0.01 (−6.4, 7.0) >0.99
No. of cases receiving intravenous fluid (%) 260 44 (16.9) 177 31 (17.5) −0.6 (−8.4, 6.8) 0.90
No. of hospitalizations (%) 258 14 (5.4) 175 12 (6.9) −1.4 (−7.0, 3.4) 0.68
Median MVS score (IQR) 257 13.0 (11.0, 15.0) 173 12.0 (10.0, 15.0) 0 (0, 1.0) 0.17
a

ED, emergency department; MVS, modified Vesikari scale; HAdV, human adenovirus.

b

Maximal number of episodes in a given 24 h.

c

Fever was defined as a rectal temperature of ≥38.0°C. Temperatures were adjusted for the location of measurement: 1.1°C was added to axillary temperatures, and 0.6°C was added to oral temperatures.